The emerging era of structural nanomedicine.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40671716.
- Also identified by DOI 10.1038/s44222-025-00306-5 and PMC identifier 12263095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The lack of structural definition in nanomedicines limits therapeutic efficacy and complicates regulatory approval. Here, we emphasize that defining, designing and optimizing the structures of nanomedicine are critical to developing effective therapies because their architectures - not just the identity of their components - determines potency.